Stay updated on the latest news and events

5.19 - 5.22

San Diego, CA
USA

Hongene is thrilled to announce our participation in TIDES USA 2025. North America's premier forum accelerating oligonucleotide and peptide innovations through collaborative discovery, development, and commercialization - where industry pioneers explore cutting-edge strategies across oligos, peptides, mRNA, and genome editing to transform therapeutics from discovery to market reality.

Welcome to visit our booth #406. Let's discuss how Hongene's high-quality nucleic acid products and end-to-end RNA medicines solution can help make your project successful.

Featured Talk Session

Speaker: David Butler, Chief Technology Officer

Title: Chemoenzymatic Ligation for siRNA and sgRNA Manufacturing: Recent Advances and Development Strategies

Date/Time: May 22, 12:10 -12:50 p.m. EDT

Overview: In this presentation, we will share the  latest advancements in our chemoenzymatic oligonucleotide ligation platform for the synthesis of siRNA and sgRNA. We will highlight key differentiators and advantages compared to traditional solid-phase  oligonucleotide synthesis (SPOS). Additionally, we will provide  strategic insights that will help researchers and companies navigate  drug development using the ligation process. Join us to explore how this  platform is shaping the future of RNA therapeutics manufacturing.

Watch the on-demand video to explore more!